GSK Blasts Senate Report On Avandia Risks
GlaxoSmithKline PLC fired back Wednesday at a U.S. Senate Finance Committee report that alleges the company has concealed data suggesting an increased risk of heart attack linked to its diabetes drug...To view the full article, register now.
Already a subscriber? Click here to view full article